Chronic Diseases

Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, investing in innovative digital health and life sciences companies worldwide. They invest in disruptive technologies and meaningful companies with a diverse leadership team. Their investment mandate is broad, focusing on areas where they see strategic advantages for both Hikma and their portfolio companies.

Robert Bosch Venture Capital GmbH (RBVC) invests in deep-tech companies worldwide, focusing on early-stage ventures with a potential to shape the future of human living spaces. RBVC offers financial commitment and access to Bosch's vast network, supporting commercial collaborations. Their investment sweet spot is early stage, but they also consider later-stage and seed-stage companies in select cases.